Literature DB >> 27855853

Incidence and predictors of right ventricular pacing-induced cardiomyopathy in patients with complete atrioventricular block and preserved left ventricular systolic function.

Erich L Kiehl1, Tarek Makki2, Rahul Kumar2, Divya Gumber2, Deborah H Kwon3, John W Rickard4, Mohamed Kanj4, Oussama M Wazni4, Walid I Saliba4, Niraj Varma4, Bruce L Wilkoff4, Daniel J Cantillon5.   

Abstract

BACKGROUND: Right ventricular (RV) pacing may worsen left ventricular cardiomyopathy in patients with reduced left ventricular ejection fraction (LVEF) and advanced atrioventricular block.
OBJECTIVE: The objectives of this study were to calculate incidence and identify predictors of RV pacing-induced cardiomyopathy (PICM) in complete heart block (CHB) with preserved LVEF and to describe outcomes of subsequent cardiac resynchronization therapy (CRT) upgrade.
METHODS: An analysis of consecutive patients receiving permanent pacemaker (PPM) from 2000 to 2014 for CHB with LVEF >50% was performed. PICM was defined as CRT upgrade or post-PPM LVEF ≤40%. PICM association was determined via multivariable regression analysis. CRT response was defined by LVEF increase ≥10% or left ventricular end-systolic volume decrease ≥15%.
RESULTS: Of the 823 study patients, 101 (12.3%) developed PICM over the mean follow-up of 4.3 ± 3.9 years, with post-PPM LVEF being 33.7% ± 7.4% in patients with PICM vs 57.6% ± 6.1% in patients without PICM (P < .001). In multivariable analysis, lower pre-PPM LVEF (hazard ratio [HR] 1.047 per 1% LVEF decrease; 95% confidence interval [CI] 1.002-1.087; P = .042) and RV pacing % both as a continuous (HR 1.011 per 1% RV pacing; 95% CI 1.002-1.02; P = .021) and as a categorical (<20% or ≥20% RV pacing) (HR 6.76; 95% CI 2.08-22.0; P = .002) variable were independently associated with PICM. Only 29 patients with PICM (28.7%) received CRT upgrade despite an 84% responder rate (LVEF increase 18.5% ± 8.1% and left ventricular end-systolic volume decrease 45.1% ± 15.0% in responders). CRT upgrade was associated with greater post-PPM LVEF decrease, lower post-PPM LVEF, and post-PPM LVEF ≤35% (P = .006, P = .004, and P = .004, respectively).
CONCLUSION: PICM is not uncommon in patients receiving PPM for CHB with preserved LVEF and is strongly associated with RV pacing burden >20%. CRT response rate is high in PICM, but is perhaps underutilized.
Copyright © 2016 Heart Rhythm Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atrioventricular block; Cardiac resynchronization therapy; Cardiomyopathy; Complete heart block; Ejection fraction; Heart failure; Incidence; Pacing; Pacing-induced cardiomyopathy; Predictors

Mesh:

Year:  2016        PMID: 27855853     DOI: 10.1016/j.hrthm.2016.09.027

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  43 in total

1.  Incidence and predictors of pacemaker-induced cardiomyopathy with comparison between apical and non-apical right ventricular pacing sites.

Authors:  Raghav Bansal; Neeraj Parakh; Anunay Gupta; Rajnish Juneja; Nitish Naik; Rakesh Yadav; Gautam Sharma; Ambuj Roy; Sunil Kumar Verma; Vinay Kumar Bahl
Journal:  J Interv Card Electrophysiol       Date:  2019-07-30       Impact factor: 1.900

Review 2.  Permanent His bundle pacing: shaping the future of physiological ventricular pacing.

Authors:  Parikshit S Sharma; Pugazhendhi Vijayaraman; Kenneth A Ellenbogen
Journal:  Nat Rev Cardiol       Date:  2019-06-27       Impact factor: 32.419

3.  Single- and dual-site ventricular pacing entirely through the coronary sinus for patients with prior tricuspid valve surgery.

Authors:  Chin C Lee; Khuyen Do; Sati Patel; Steven K Carlson; Tomas Konecny; Philip M Chang; Rahul N Doshi
Journal:  J Interv Card Electrophysiol       Date:  2019-08-20       Impact factor: 1.900

4.  Antegrade Conduction Rescues Right Ventricular Pacing-Induced Cardiomyopathy in Complete Heart Block.

Authors:  James F Dawkins; Yu-Feng Hu; Jackelyn Valle; Lizbeth Sanchez; Yong Zheng; Eduardo Marbán; Eugenio Cingolani
Journal:  J Am Coll Cardiol       Date:  2019-04-09       Impact factor: 24.094

5.  A case report of simultaneous His pacemaker implantation and atrioventricular junction ablation following unsuccessful treatment of atrial fibrillation.

Authors:  Dirk Grosse Meininghaus; Martin Lengiewicz; Kai Blembel; Juergen Kruells-Muench
Journal:  Eur Heart J Case Rep       Date:  2020-08-05

6.  Trends in Cardiovascular Implantable Electronic Device Insertion Between 1988 and 2018 in Olmsted County.

Authors:  Vaibhav R Vaidya; Roshini Asirvatham; Gurukripa N Kowlgi; Ming-Yan Dai; Jordan J Cochuyt; David O Hodge; Abhishek J Deshmukh; Yong Mei Cha
Journal:  JACC Clin Electrophysiol       Date:  2021-08-25

7.  Clinical characteristics associated with pacing-induced cardiac dysfunction: a high incidence of undiagnosed cardiac sarcoidosis before permanent pacemaker implantation.

Authors:  Yasushi Wakabayashi; Takeshi Mitsuhashi; Naoyuki Akashi; Takekuni Hayashi; Tomio Umemoto; Yoshitaka Sugawara; Hideo Fujita; Shin-Ichi Momomura
Journal:  Heart Vessels       Date:  2018-06-21       Impact factor: 2.037

Review 8.  The therapeutic effects of upgrade to cardiac resynchronization therapy in pacing-induced cardiomyopathy or chronic right ventricular pacing patients: a meta-analysis.

Authors:  Wenzhao Lu; Jinxuan Lin; Yan Dai; Keping Chen; Shu Zhang
Journal:  Heart Fail Rev       Date:  2021-02-27       Impact factor: 4.214

9.  Predictors of Pacemaker-Induced Cardiomyopathy and Importance of Nutritional Status and Prognostic Nutritional Index.

Authors:  Mehmet Balli; Mustafa Çetin; Fatma Koksal; Fazilet Erturk Sag; Fahrettin Katkat; Esra Erturk Tekin; Bahar Aydinli; Veysel Kutay Vurgun
Journal:  Acta Cardiol Sin       Date:  2022-03       Impact factor: 2.672

10.  Clinical Outcomes in Patients With Left Bundle Branch Area Pacing vs. Right Ventricular Pacing for Atrioventricular Block.

Authors:  Xiaofei Li; Junmeng Zhang; Chunguang Qiu; Zhao Wang; Hui Li; Kunjing Pang; Yan Yao; Zhimin Liu; Ruiqin Xie; Yangxin Chen; Yongquan Wu; Xiaohan Fan
Journal:  Front Cardiovasc Med       Date:  2021-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.